Dr. Jonathan Kiefer has been accepted into the ETH Pioneer Fellowship Program in 2019. This will help in the further development of his antibody-based therapy for AML patients.
The Pioneer Fellowship is an extensive support program that provides innovative thinkers and creators ideal conditions for starting their entrepreneurship journey.
